Description
OVERVIEWProduct overview
Hexarelin is a synthetic hexapeptide secretagogue closely related to GHRP-6, distinguished by a methylated tryptophan residue.
Alongside pituitary work, it appears in cardiovascular literature because of reported binding to CD36 in cardiac tissue, a receptor interaction not shared by all peptides in the class.
Laboratory research use only.
SUPPLY IN IRELANDHexarelin Acetate Ireland — supplied to research laboratories
Research groups across Ireland buy Hexarelin Acetate from Kensington Laboratories as a lyophilised Hexarelin Acetate peptide, released only against a batch-matched certificate of analysis. Every vial of high purity Hexarelin Acetate is verified by HPLC and LC-MS before it leaves the facility, so laboratories ordering Hexarelin Acetate in Ireland receive material with documented purity and identity.
Laboratory Hexarelin Acetate is packed for controlled storage and sent by tracked delivery in 3–5 days to Dublin, Cork, Galway, Limerick and the rest of Ireland. Delivery costs €9.90 per order. Teams planning HexarelinAcetate research can review the specifications, certificate of analysis and reference list on this page before ordering.
Institutions searching for Hexarelin Acetate peptide suppliers in Ireland typically compare purity, batch documentation and delivery times. Each of those is published here: a 99% HPLC purity specification, a certificate matched to the batch code on your vial, and tracked delivery in 3–5 days.
Hexarelin Acetate is supplied strictly for laboratory research use only. It is not a medicine and is not for human or veterinary consumption.
SPECIFICATIONSProduct specifications
- Purity: ≥ 99% (HPLC)
- Appearance: White lyophilised powder
- Quantity: 5 mg per vial
- CAS number: 140703-51-1
- Peptide class: Synthetic growth hormone releasing hexapeptide
- Also known as: Examorelin
- Solubility: Soluble in bacteriostatic or sterile water
- Storage temperature: Store at 2–8°C; long-term −20°C, protected from light
- Shelf life: 24 months lyophilised; 30 days reconstituted at 2–8°C
- Manufacturing standard: ISO 9001 facility, GMP-aligned solid-phase synthesis
- Batch information: Batch number and expiry printed on every vial label
RESEARCHResearch overview
The following summary is provided for educational and scientific context only. It describes what has been observed in published laboratory and animal studies and does not represent established clinical outcomes, medical advice or a claim of efficacy in humans.
Background
Hexarelin is a synthetic hexapeptide secretagogue closely related to GHRP-6, distinguished by a methylated tryptophan residue.
Alongside pituitary work, it appears in cardiovascular literature because of reported binding to CD36 in cardiac tissue, a receptor interaction not shared by all peptides in the class.
Laboratory research use only.
Current research areas
Published investigation clusters around a small number of biological themes. Each remains experimental and none has been established as a therapeutic effect in humans.
- GHS-R1a receptor binding assays
- CD36 receptor interaction in cardiac tissue
- Cardiac injury and protection models
- Structure–activity work within the GHRP family
Scientific context and proposed mechanisms
The peptide engages the growth hormone secretagogue receptor at the pituitary and, separately, has been reported to bind CD36 in cardiac tissue.
The cardiac receptor interaction is the reason hexarelin features in cardiovascular models rather than endocrine work alone.
Interpreting the evidence
Most published work in this area uses cell culture or rodent models with small group sizes and short observation windows. Independent replication varies considerably between compounds, and results are sensitive to species, route, dose and endpoint.
There is no regulatory-approved human protocol for this compound. Any laboratory protocol should be defined by the model under study, institutional ethical approval, appropriate controls and predefined endpoints.
References
CERTIFICATE OF ANALYSISIndependent batch testing
Every released batch is independently tested. Match the batch number on the vial to the certificate published online.
- Batch number
- KL-HEXARELINA-2405A
- Testing laboratory
- Janoshik Analytical, s.r.o.
- Date tested
- 14 May 2026
- Reported purity
- 99.03%
- Method
- RP-HPLC with UV detection at 214 nm, confirmed by LC-MS
